111 filings
Page 5 of 6
6-K
p7tlw 4ch
13 Nov 19
Current report (foreign)
4:00pm
6-K
q2jwbm
7 Nov 19
Current report (foreign)
7:01am
6-K
mbcod
6 Nov 19
Orchard Therapeutics to Present New Registrational Data of Investigational Gene Therapies at the 61st American Society of Hematology Annual Meeting
4:07pm
6-K
zi4lqj cm0tbslwim
22 Oct 19
Orchard Therapeutics Presents Data from OTL-200 in Patients with Metachromatic Leukodystrophy Using Cryopreservation
4:02pm
6-K
ztlkwll2bks39e
30 Sep 19
Initial Results from Cryopreserved Formulation Clinical Trial Accepted as Poster Presentation
4:00pm
6-K
98rwsrxf5q84v644l
13 Sep 19
Orchard Therapeutics Announces Departure of Chief Commercial Officer
4:00pm
6-K
p1ejg9 j2cy9h11x20
4 Sep 19
Form 6-K - 4 Sept 2019
4:41pm
6-K
6wdfik8
30 Aug 19
6-K 8-30-2019
4:30pm
6-K
kh7jtoc1c7xzo
8 Aug 19
Current report (foreign)
7:17am
6-K
3o7b7n7
30 Jul 19
Three-Year Registrational Data Set to be Presented by Year End 2019
4:00pm
6-K
qxrudh kfnb5mux9zd
1 Jul 19
Current report (foreign)
5:03pm
6-K
v6l6dt
6 Jun 19
Orchard Therapeutics Launches Proposed Public Offering
4:31pm
6-K
i8ufsbnqg9
3 Jun 19
Current report (foreign)
7:00am
6-K
gw4pac
28 May 19
Current report (foreign)
7:23am
6-K
wclp7mxipnky7cgxhynz
28 May 19
Current report (foreign)
7:18am
6-K
x00 41f7sa9756i349y
28 May 19
Orchard Therapeutics, Fondazione Telethon and Ospedale San Raffaele Announce Exclusive
7:15am
6-K
cj00p92
29 Apr 19
Current report (foreign)
1:40pm
6-K
9t33bn2gq80e6 p9l
25 Apr 19
Program on Track for MAA and BLA Regulatory Submissions in 2021
4:00pm
6-K
313ecicawbi0x5b7v4v4
15 Apr 19
Data Supports Achievement of Proof-of-Concept Milestone for OTL-300
4:00pm
6-K
me5oo mk749
27 Mar 19
Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD
9:36am